Naive CD8+ T cells do not require costimulation for proliferation and differentiation into cytotoxic effector cells

被引:91
作者
Wang, B
Maile, R
Greenwood, R
Collins, EJ
Frelinger, JA
机构
[1] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA
[2] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA
关键词
D O I
10.4049/jimmunol.164.3.1216
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Most current models of T cell activation postulate a requirement for two distinct signals. One signal is delivered through the TCR by engagement with peptide/MHC complexes, and the second is delivered by interaction between costimulatory molecules such as CD28 and its ligands CD80 and CD86, Soluble peptide/MHC tetramers provide an opportunity to test whether naive CD8(+) T cells can be activated via the signal generated through the TCR-alpha beta in the absence of any. potential costimulatory molecules. Using T cells from two different TCR transgenic mice in vitro, we find that TCR engagement by peptide/MHC tetramers is sufficient for the activation of naive CD8(+) T cells. Furthermore, these T cells proliferate, produce cytokines, and differentiate into cytolytic effecters. Under the conditions where anti-CD28 is able to enhance proliferation of normal B6 CD4(+), CD8(+), and TCR transgenic CD8(+) T cells with anti-CD3, we see no effect of anti-CD28 on proliferation induced by tetramers, The results of this experiment argue that given a strong signal delivered through the TCR by an authentic ligand, no costimulation is required.
引用
收藏
页码:1216 / 1222
页数:7
相关论文
共 51 条
[1]   T cell responses are governed by avidity and co-stimulatory thresholds [J].
Bachmann, MF ;
Sebzda, E ;
Kundig, TM ;
Shahinian, A ;
Speiser, DE ;
Mak, TW ;
Ohashi, PS .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1996, 26 (09) :2017-2022
[2]  
Baskar S, 1996, J IMMUNOL, V156, P3821
[3]   Initiation of signal transduction through the T cell receptor requires the peptide multivalent engagement of MHC ligands [J].
Boniface, JJ ;
Rabinowitz, JD ;
Wülfing, C ;
Hampl, J ;
Reich, Z ;
Altman, JD ;
Kantor, RM ;
Beeson, C ;
McConnell, HM ;
Davis, MM .
IMMUNITY, 1998, 9 (04) :459-466
[4]  
Butz EA, 1998, J IMMUNOL, V160, P2139
[5]   COEXPRESSION OF B7-1 AND ICAM-1 ON TUMORS IS REQUIRED FOR REJECTION AND THE ESTABLISHMENT OF A MEMORY RESPONSE [J].
CAVALLO, F ;
MARTINFONTECHA, A ;
BELLONE, M ;
HELTAI, S ;
GATTI, E ;
TORNAGHI, P ;
FRESCHI, M ;
FORNI, G ;
DELLABONA, P ;
CASORATI, G .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1995, 25 (05) :1154-1162
[6]   TUMOR IMMUNOGENICITY DETERMINES THE EFFECT OF B7 COSTIMULATION ON T-CELL-MEDIATED TUMOR-IMMUNITY [J].
CHEN, LP ;
MCGOWAN, P ;
ASHE, S ;
JOHNSTON, J ;
LI, YW ;
HELLSTROM, I ;
HELLSTROM, KE .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 179 (02) :523-532
[7]   COSTIMULATION OF ANTITUMOR IMMUNITY BY THE B7 COUNTERRECEPTOR FOR THE LYMPHOCYTE-T MOLECULES CD28 AND CTLA-4 [J].
CHEN, LP ;
ASHE, S ;
BRADY, WA ;
HELLSTROM, I ;
HELLSTROM, KE ;
LEDBETTER, JA ;
MCGOWAN, P ;
LINSLEY, PS .
CELL, 1992, 71 (07) :1093-1102
[8]   Ligand recognition by αβ T cell receptors [J].
Davis, MM ;
Boniface, JJ ;
Reich, Z ;
Lyons, D ;
Hampl, J ;
Arden, B ;
Chien, YH .
ANNUAL REVIEW OF IMMUNOLOGY, 1998, 16 :523-+
[9]   CD8 expression allows T cell signaling by monomeric peptide-MHC complexes [J].
Delon, J ;
Grégoire, C ;
Malissen, B ;
Darche, S ;
Lemaître, F ;
Kourilsky, P ;
Abastado, JP ;
Trautmann, A .
IMMUNITY, 1998, 9 (04) :467-473
[10]   CLONING OF B7-2 - A CTLA-4 COUNTER-RECEPTOR THAT COSTIMULATES HUMAN T-CELL PROLIFERATION [J].
FREEMAN, GJ ;
GRIBBEN, JG ;
BOUSSIOTIS, VA ;
NG, JW ;
RESTIVO, VA ;
LOMBARD, LA ;
GRAY, GS ;
NADLER, LM .
SCIENCE, 1993, 262 (5135) :909-911